Literature DB >> 11180171

Increased expression of matrix metalloproteinase-9 in nasal polyps.

E Lechapt-Zalcman1, A Coste, M P d'Ortho, E Frisdal, A Harf, C Lafuma, E Escudier.   

Abstract

To investigate the role of gelatinases in nasal polyposis, a common and disabling airway disease characterized by chronic inflammation and tissue remodelling, matrix metalloproteinase-2 (MMP-2) and MMP-9 expression was investigated in the nasal polyps (NP) of 24 patients undergoing ethmoidectomy and compared with 15 control nasal mucosal (CM) samples obtained from snorers during turbinectomy. Tissue samples were either frozen for enzymatic analysis or paraffin wax-embedded for immunohistochemistry. Zymography and quantitative image analysis showed that MMP-9 active forms were significantly increased (p<0.05) in NPs compared to CM (44 +/- 40 versus 13 +/- 19x10(3) AU/10 microg protein), while MMP-2 expression was similar in both tissues. Concomitant studies of gelatinase immunoexpression showed that MMP-9 expression was enhanced (4- to 16-fold) in surface epithelium, glands (p<0.05), and submucosal inflammatory cells (p<0.05). In addition, MMP-9 positivity was markedly increased in endothelial cells (p<0.01). In situ zymography demonstrated marked gelatinolytic activity, consistent with the immunolocalization of MMP-2 and MMP-9. These results suggest up-regulation of active MMP-9 in the glands and vessels characteristic of NPs. It is concluded that MMP-9 may play a role in the upper airway remodelling observed during nasal polyposis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180171     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH771>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Vitamin D deficiency is associated with increased human sinonasal fibroblast proliferation in chronic rhinosinusitis with nasal polyps.

Authors:  William W Carroll; Rodney J Schlosser; Brendan P O'Connell; Zachary M Soler; Jennifer K Mulligan
Journal:  Int Forum Allergy Rhinol       Date:  2016-01-11       Impact factor: 3.858

2.  Does procalcitonin have a role in the pathogenesis of nasal polyp?

Authors:  Suat Bilici; Zehra Cinar; Ozgur Yigit; Mustafa Cakir; Enes Yigit; Hafize Uzun
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-09       Impact factor: 2.503

Review 3.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Matrix metalloproteinases and their impact on sinusal extension in chronic rhinosinusitis with nasal polyps.

Authors:  Rafael Rossell Malinsky; Fabiana C P Valera; Fransérgio Emílio Cavallari; Daniel Salgado Küpper; Cristiane Milaneze; João S Silva; Edwin Tamashiro; Wilma T Anselmo-Lima
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-12       Impact factor: 2.503

5.  Evaluation of MMP-9 and TIMP-1 Levels of the Patients with Nasal Polyposis After Corticosteroid Therapies.

Authors:  Hakan Cincik; Evren Erkul; Dogan Pinar; Osman Ipcioglu; Atila Gungor; Engin Cekin; Adem Cakmak
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-04-25

6.  Chronic rhinosinusitis with and without nasal polyps: what is the difference?

Authors:  Wouter Huvenne; Nicholas van Bruaene; Nan Zhang; Thibaut van Zele; Joke Patou; Philippe Gevaert; Sofie Claeys; Paul Van Cauwenberge; Claus Bachert
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

Review 7.  Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps.

Authors:  Ruby Pawankar; Manabu Nonaka
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

Review 8.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

9.  Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.

Authors:  V Bjerkeli; B Halvorsen; J K Damås; I Nordøy; A Yndestad; P Aukrust; S S Frøland
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

10.  Drug management in chronic rhinosinusitis: identification of the needs.

Authors:  Jean-Baptiste Hpj Watelet; Philippe H Eloy; Paul B van Cauwenberge
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.